| Vertex Pharmaceuticals | 200.3800 / -0.92% |
| Date/Time | 07/29 / 22:00 |
| Chg. / Chg.(%) | -1.8600 / -0.92% |
| Bid | 200.0000 / 200 |
| Ask | 203.0000 / 100 |
| Open | 202.7253 |
| Previous Close | 202.2400 |
| High | 202.9400 |
| Low | 198.8300 |
| Volume [USD] | 187,490,636.4923 |
| Volume [Units] | 1,396,984 |
| Price fixings | 5705 |
| ISIN | US92532F1003 |
| Security | VRTX |
| Exchange | NASDAQ |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| IEX | 199.87 |  |
1,362 |
| TradeGate | 168.420 | |
568 |
| Moscow | 14,671.00 | |
174 |
| Vienna Globa.. | 168.78 | |
49 |
| Xetra | 169.00 | |
14 |
| gettex | 168.300 | |
6 |
| Frankfurt | 167.4000 |  |
0 |
| München | 167.84 | |
0 |
| Düsseldorf | 168.20 | |
0 |
| Berlin | 168.16 | |
0 |
| Hannover | 167.78 | |
0 |
| Hamburg | 167.80 | |
0 |
| Lang & Schwa.. | 167.660 | |
|
| Stuttgart | 168.360 | |
|
| Quotrix | 168.6600 | |
|
| NASDAQ | 200.3800 | |
1,396,984 |
| Cboe US | 200.35 | 73,510 | |
| London Inter.. | 200.47 | 1,235 | |
| Mexico | 3,976.00 | |
500 |
News
- CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
07/29/2021 / 22:30 - GlobeNewswire - Arbor Strengthens Focus on Therapeutics with Key Additions to Leadership Team
07/20/2021 / 14:00 - GlobeNewswire - Arbor Biotechnologies to Present at the Raymond James Human Health Innovation Conference
06/21/2021 / 14:00 - GlobeNewswire - CRISPR Therapeutics and Capsida Biotherapeutics Announce Strategic Collaboration to Develop Gene-Edited Therapies for Amyotrophic Lateral Sclerosis and Friedreich’s Ataxia
06/15/2021 / 13:15 - GlobeNewswire - Wall Street opens mixed as G7 summit continues
06/11/2021 / 15:31 - TeleTrader
Real-time